Dexcom launches its VC fund

Called Dexcom Ventures, it aims to identify and invest in transformational technologies to advance long-term growth.

Dexcom building

DexCom, which is best known for its continuous glucose monitoring products and services, is launching its VC arm – Dexcom Ventures. The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

Why does it matter?

Dexcom Ventures will be led by Dexcom veteran Steve Pacelli and will be focused on investment opportunities in sensing technology, data analytics, remote patient monitoring and population health, broadening Dexcom’s commitment to advancing better outcomes in healthcare.

The fund will support independent initiatives in glucose sensing technologies and in adjacent fields of metabolic monitoring and marks the entrance into the venture capital space for parent company Dexcom.

On the record

“Driven by core technologies that our teams have developed internally, Dexcom continues to achieve strong growth and expand our future markets,” said Kevin Sayer, chairman, president and CEO of Dexcom. “By establishing Dexcom Ventures, we believe we can advance innovative technologies that enable better health outcomes and complement our growth opportunity. I have full confidence in Steve and his team as they lead this exciting new effort.”

“We strive to be value-add strategic investors by leveraging access to Dexcom’s unique industry expertise and technology leadership,” Pacelli said. “While we have matured as a company over the years, we still consider ourselves to be a ‘start-up’ of sorts. We feel well-positioned to invest early and support our portfolio companies as they pioneer markets.”

The context

DexCom is by no means the only health-tech company looking to invest in digital health startups. Pretty much all major tech companies have their VC arms and so do many of the established health IT giants and pharmaceuticals.

DexCom has seemingly realized that getting close to startups could provide them the first-hand opportunity to test out new technologies, create new partnerships and perhaps even acquire promising startups. Sounds like a plan.